July 9, 2026
Tonight: a quiet rule change on ER oversight (does it matter?), maternity wards still closing, ovarian cancer caught too late, and more.
— Meghan McCarthy
p.s. Tonight’s trivia: What’s actually killing most women?
WHO CHECKS WHETHER THE ER TURNED YOU AWAY? SOON, MAYBE A PRIVATE FIRM.
Buried in Medicare's 2027 outpatient payment rule, CMS proposes letting private accrediting organizations verify compliance with parts of EMTALA, the law that requires all hospitals to stabilize patients in need, even if they don’t have health insurance. One of those duties is keeping a log of everyone who arrives at the ER, and that’s important for documenting women sent home mid-miscarriage or ectopic pregnancy because the hospital refused to provide an abortion. (See the horror story of Kayleigh Thurman.) CMS used to check on the record-keeping function, but here they are trying to hand it off to accreditation bodies paid by the hospitals themselves. It also means the records could be largely exempt from public-disclosure rules that cover state inspections. Comments run through August 31.
A YEAR AFTER THE MEGABILL, MATERNITY WARDS KEEP CLOSING
One year after Republicans' “big beautiful bill” took effect, maternity units around the country are closing, scaling back, or shelving expansion plans, according to a report from Democratic Rep. Frank Pallone and Sen. Ron Wyden. The law's cuts to Medicaid payments, which many rural hospitals rely on to keep labor and delivery open, don't formally take effect until 2027. But the report says providers are already cutting services as they budget for the losses. Rural maternity deserts predate the bill, but the direction it describes is well documented and amplified after this legislation passed. Pallone calls it the largest closure of labor and delivery services the country has seen.
TWO IN FIVE OVARIAN CANCERS ARE CAUGHT ONLY IN THE ER
Forty percent of women with ovarian cancer in England were diagnosed only after an emergency hospital admission, and those women were four times more likely to die within two months than women diagnosed through other routes, a University of Surrey team found in an analysis of more than 28,000 cases in BMJ Oncology. One-year survival for the emergency-diagnosis group was 50%, versus 83% for everyone else, largely because their cancer was caught later. The pattern was worst for the youngest and oldest patients, and in poorer areas. Ovarian cancer has vague symptoms and no screening program, which researchers say clinicians and patients need to be more vigilant about the symptoms.
THE PILL CAN MATCH AN IUD, GIVEN THE RIGHT SUPPORT
The idea that IUDs and implants are far more effective than the pill or the ring may have less to do with the methods than with the access around them. In the HER Salt Lake initiative, more than 4,000 low-income women got contraceptive counseling built around their own priorities, including starting on the day they visited the clinic and dependable refills. With that approach University of Utah researchers reported in JAMA Network Open that failure rates were similarly low across nearly every method. About one pregnancy per 100 women a year, whether using an IUD or the pill. That's a striking break from a much-cited 2012 study that put the pill, patch, and ring at roughly 20 times the failure rate of long-acting methods. The authors argue that support closes the everyday gaps usually blamed on the patient: the missed refill, the skipped appointment, the out-of-pocket cost.
MENOPAUSE'S MISSING SYMPTOM ISN'T IRRITABILITY. IT'S RAGE.
In an essay for TIME, OB-GYN Dr. Sarah Berg argues the public menopause conversation has focused on symptoms that are easiest to name, including hot flashes, sleep loss, and brain fog. But it has skipped the one doing the most professional damage: rage. The science is thin, she writes, as perimenopausal mood gets studied as depression or folded into an anxiety cluster, with no guideline or diagnostic name for rage itself. A federally funded UNC trial has started examining perimenopausal irritability, but rage on its own remains studied just enough to confirm it's real and no further. Berg founded Selfority, which sells menopause education to employers, so she has a stake in the workplace case she's making, but the clinical gap she describes is real.